Most Women No Longer Wishing To Have Children Do Not Discuss Their Options With Their OB GYNs
Women don't know about non-surgical permanent birth control, including the Essure procedure which is celebrating its 10 year anniversary at the AAGL 40th Global Congress of Minimally Invasive Gynecology A recent first-of-its-kind survey of 1, 006 mothers in the U.S. showed that more than 75 percent of women reported being done having children, but only 24 percent discussed this decision with their OB/GYNs. Without these important patient-physician conversations taking place, the survey found that women remain largely unaware of their permanent birth control options.
Rectal Microbicide Safe, Could Significantly Reduce HIV Transmission, Early Trial Suggests
A topically applied microbicide gel containing a potent anti-HIV drug has been found to significantly reduce infection when applied to rectal tissue that was subsequently exposed to HIV in the laboratory, according to a new study by the UCLA AIDS Institute. The gel was also found to be safe and acceptable to users. The first-ever phase 1 clinical trial of the rectal HIV-prevention drug known as UC781, a non-nucleoside reverse transcriptase inhibitor, is described in the current edition of the online journal PLoS ONE.
Seeking New Weapons Against Malaria With The Help Of 'Protein Microarrays'
A new research technology is revealing how humans develop immunity to malaria, and could assist programs aimed at eradicating this parasitic disease. Dr Alyssa Barry from the Walter and Eliza Hall Institute's Infection and Immunity division is using 'protein microarray' technology to screen human blood serum samples for immunity to proteins produced by the malaria-causing Plasmodium falciparum parasite. Her research, which determines a person's immunity to hundreds of proteins simultaneously, has been published in the journal Molecular and Cellular Proteomics this month.